Do you know the number for ?
lorazepam ativan end stage ovarian In addition, Mr. Sperling said that having analysts who were too bullish wouldn't necessarily be helpful for issuers of stock. "You don't necessarily want analyst who has a reputation for supporting just any deal that comes along," he said.